Our findings provide new insights into the anti-cancer potential of DHC and suggest that it may serve as a valuable adjuvant agent to overcome survival signaling and improve the efficacy of TNF-α-based therapeutic strategies in cervical cancer. Here, TNF is linked to cervical carcinoma.